Biogen Inc.BIIBNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank14
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P14
Within normal range
vs 5Y Ago
-0.3x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -21.45% |
| 2024 | -7.92% |
| 2023 | 4.07% |
| 2022 | -23.63% |
| 2021 | -24.95% |
| 2020 | 63.53% |
| 2019 | 2.24% |
| 2018 | 14.16% |
| 2017 | 20.29% |
| 2016 | -1.96% |